Champions Oncology
CSBR
14 hedge funds and large institutions have $15.6M invested in Champions Oncology in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
1.04% more ownership
Funds ownership: 37.88% → 38.92% (+1%)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
4% less capital invested
Capital invested by funds: $16.2M → $15.6M (-$572K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$521K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$163K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$4.86K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.56K |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$22 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$73K |
| 2 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$63.4K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$59K |
| 4 |
Millennium Management
New York
|
-$55K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.91K |
CSBR Hedge Fund Activity: Q1 2018 in Review
14 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q1 2018, worth a combined $15.6M — down 3.5% from $16.2M a quarter earlier.
Fund positioning in CSBR was balanced in Q1 2018: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was Granite Investment Partners, opening a new position worth an estimated $521K. The largest seller was Perceptive Advisors, cutting an estimated $73K.
- 14 institutional investors held Champions Oncology (CSBR) as of Q1 2018, unchanged from Q4 2017.
- Funds reported $15.6M of Champions Oncology stock for Q1 2018, down 3.5% quarter-over-quarter.
- 3 funds opened new Champions Oncology positions in Q1 2018 and 3 closed out, a net change of 0 holders.
- The largest Champions Oncology buyer in Q1 2018 was Granite Investment Partners, an estimated $521K added.
- The largest Champions Oncology seller in Q1 2018 was Perceptive Advisors, an estimated $73K sold.
Based on aggregated 13F filings for Q1 2018.